Alvin J. Siteman, left, had an extraordinary vision: Create an “institution of world-class cancer research, combined with compassionate cancer care, to provide longer life and lasting hope for generations to come.” Such partnerships are led by Timothy J. Eberlein, MD, director of the Siteman Cancer Center, the Spencer T. and Ann W. Olin Distinguished Professor and chair of the Department of Surgery at the School of Medicine.
BY STEPHANIE STEMMLER
At the forefront of personalized medicine, Washington University is conducting groundbreaking research to identify genetic and molecular changes that trigger cancer. We are translating that research into innovative diagnostic tools for individualized treatment. Our oncologists and radiologists are inventing better technologies to identify cancers and pinpoint their treatments. The result? Patients receive personalized care that is more effective and easier to tolerate.
More than 350 Washington University physicians and researchers are engaged in cancer treatment and research. And the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine serves more than 50,000 cancer patients annually. From prevention to care, education, research and outreach, Siteman Cancer Center is recognized as one of the great Comprehensive Cancer Centers in the United States by the National Cancer Institute. Our physicians help set national and global standards for cancer treatment as one of only 23 centers in the National Comprehensive Cancer Network.
Physicians at the School of Medicine and Siteman use a collaborative, multidisciplinary team approach to tackling cancer. Through investments in prevention, education, care and research, they say, the day will come when most cancers are preventable or treatable.
MULTIFACETED EFFORTS
COMBINED STRENGTHS
INNOVATIVE IMAGING
SEEKING CANCER'S ROOTS
GENETIC FINGERPRINTS
FINDING NEW THERAPIES
For more information, view the stories above, and visit:
